Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Depreciation & Amortization (CF) (2025 - 2026)

MDxHealth has reported Depreciation & Amortization (CF) over the past 2 years, most recently at $1.1 million for Q1 2026.

  • For Q1 2026, Depreciation & Amortization (CF) rose 21.62% year-over-year to $1.1 million; the TTM value through Mar 2026 reached $2.0 million, up 121.62%, while the annual FY2025 figure was $4.0 million, 28.14% up from the prior year.
  • Depreciation & Amortization (CF) was $1.1 million for Q1 2026 at MDxHealth, up from $925000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $1.1 million in Q1 2026 and bottomed at $925000.0 in Q1 2025.